Avanos Medical, Inc. (AVNS)Healthcare | Medical Devices | Alpharetta, United States | NYSE
24.93 USD
After hours: 24.93 |
Hot Take ↕ | July 11, 2026, 5:16 a.m. EDT
The investment case for Avanos Medical has collapsed due to a catastrophic multi-year price trajectory and deteriorating fundamentals. The stock has lost over 65% of its value over the last nine years, with four consecutive years of negative annual returns ending in a sharp 43.67% drop. This structural decline is compounded by negative earnings growth, negative return on equity, and a forward P/E that implies profitability only if the company turns around significantly. While the recent news of a $1.27 billion buyout offer provides a temporary floor and explains the lack of further selling pressure, it does not constitute a long-term business recovery. The market is correctly pricing this as a distressed asset rather than a growth story. With no dividend history to provide income and a balance sheet showing debt exceeding cash, there is no margin of safety for a traditional investor. The short-term outlook remains neutral-to-bearish as the market digests the takeover terms, but the long-term outlook is severely compromised by the proven inability of the business to sustain value creation. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.007488 |
| AutoETS | 0.007534 |
| AutoTheta | 0.026881 |
| MSTL | 0.049813 |
| MSTL_105 | 0.078262 |
| MSTL_79 | 0.079349 |
| MSTL_79_105 | 0.085708 |
Forecast horizon: 60 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 13.89 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.066 |
| Excess Kurtosis | -1.47 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 17.696 |
| Revenue per Share | 15.429 |
| Market Cap | 1,167,916,032 |
| Forward P/E | 19.94 |
| Beta | 1.57 |
| Profit Margins | -10.39% |
| Website | https://avanos.com |
As of July 11, 2026, 5:16 a.m. EDT: Speculators are overwhelmingly positioning for downside protection, evidenced by massive open interest in out-of-the-money puts compared to negligible call volume. The heavy concentration of put contracts at strikes below the current price suggests a consensus expectation of further decline or a failed bid, while call activity remains minimal and focused on near-term anchors.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.1020236 |
| Address1 | 5,405 Windward Parkway |
| Address2 | Suite 100 South |
| All Time High | 72.96 |
| All Time Low | 9.303 |
| Ask | 24.95 |
| Ask Size | 3,700 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 886,630 |
| Average Daily Volume3 Month | 1,670,734 |
| Average Volume | 1,670,734 |
| Average Volume10Days | 886,630 |
| Beta | 1.569 |
| Bid | 24.93 |
| Bid Size | 7,100 |
| Board Risk | 1 |
| Book Value | 16.757 |
| City | Alpharetta |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.93 |
| Current Ratio | 2.477 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 24.96 |
| Day Low | 24.93 |
| Debt To Equity | 17.696 |
| Display Name | Avanos Medical |
| Earnings Call Timestamp End | 1,771,941,600 |
| Earnings Call Timestamp Start | 1,771,941,600 |
| Earnings Growth | -0.217 |
| Earnings Quarterly Growth | -0.227 |
| Earnings Timestamp | 1,777,984,200 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | 55,900,000 |
| Ebitda Margins | 0.07808 |
| Enterprise To Ebitda | 22.185 |
| Enterprise To Revenue | 1.732 |
| Enterprise Value | 1,240,142,080 |
| Eps Current Year | 1.0 |
| Eps Forward | 1.25 |
| Eps Trailing Twelve Months | -1.6 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 24.8456 |
| Fifty Day Average Change | 0.08440018 |
| Fifty Day Average Change Percent | 0.0033969868 |
| Fifty Two Week Change Percent | 110.20236 |
| Fifty Two Week High | 25.49 |
| Fifty Two Week High Change | -0.55999947 |
| Fifty Two Week High Change Percent | -0.02196938 |
| Fifty Two Week Low | 9.303 |
| Fifty Two Week Low Change | 15.627 |
| Fifty Two Week Low Change Percent | 1.6797806 |
| Fifty Two Week Range | 9.303 - 25.49 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,413,898,200,000 |
| Float Shares | 46,025,962 |
| Forward Eps | 1.25 |
| Forward P E | 19.944 |
| Free Cashflow | 17,050,000 |
| Full Exchange Name | NYSE |
| Full Time Employees | 2,287 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.50049 |
| Gross Profits | 358,300,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03282 |
| Held Percent Institutions | 0.92551005 |
| Implied Shares Outstanding | 46,847,816 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. |
| Long Name | Avanos Medical, Inc. |
| Market | us_market |
| Market Cap | 1,167,916,032 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_251719973 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -74,400,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,167,916,052 |
| Open | 24.93 |
| Operating Cashflow | 36,700,000 |
| Operating Margins | 0.053790003 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 844 428 2667 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 24.93 |
| Post Market Time | 1,783,981,119 |
| Previous Close | 24.93 |
| Price Eps Current Year | 24.93 |
| Price Hint | 2 |
| Price To Book | 1.4877365 |
| Price To Sales Trailing12 Months | 1.6313955 |
| Profit Margins | -0.10393 |
| Quick Ratio | 1.285 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 24.96 |
| Regular Market Day Low | 24.93 |
| Regular Market Day Range | 24.93 - 24.96 |
| Regular Market Open | 24.93 |
| Regular Market Previous Close | 24.93 |
| Regular Market Price | 24.93 |
| Regular Market Time | 1,783,972,802 |
| Regular Market Volume | 339,762 |
| Return On Assets | 0.0095 |
| Return On Equity | -0.09177 |
| Revenue Growth | 0.088 |
| Revenue Per Share | 15.429 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 46,847,816 |
| Shares Percent Shares Out | 0.0379 |
| Shares Short | 1,774,282 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,161,564 |
| Short Name | Avanos Medical, Inc. |
| Short Percent Of Float | 0.0446 |
| Short Ratio | 1.45 |
| Source Interval | 15 |
| State | GA |
| Symbol | AVNS |
| Total Cash | 65,600,000 |
| Total Cash Per Share | 1.401 |
| Total Debt | 138,400,000 |
| Total Revenue | 715,900,032 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.6 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.2518 |
| Two Hundred Day Average Change | 8.6782 |
| Two Hundred Day Average Change Percent | 0.5339839 |
| Type Disp | Equity |
| Volume | 339,762 |
| Website | https://avanos.com |
| Zip | 30,004 |